Individuals with Alzheimer’s disease (AD) usually have decreased Aβ 42 but increased total-tau (T-tau) and phosphorylated tau (P-Tau) in cerebrospinal fluid (CSF).
Einstaklingar með Alzheimer sjúkdóminn (AS) hafa yfirleitt lágt Aβ 42 en hækkað heildar-tau (T-tau) og fosfór-tau (P-Tau) í mænuvökva.